ATG4C_HUMAN - dbPTM
ATG4C_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ATG4C_HUMAN
UniProt AC Q96DT6
Protein Name Cysteine protease ATG4C
Gene Name ATG4C
Organism Homo sapiens (Human).
Sequence Length 458
Subcellular Localization Cytoplasm.
Protein Description Cysteine protease required for the cytoplasm to vacuole transport (Cvt) and autophagy. Is not essential for autophagy development under normal conditions but is required for a proper autophagic response under stressful conditions such as prolonged starvation (By similarity). Cleaves the C-terminal amino acid of ATG8 family proteins MAP1LC3 and GABARAPL2, to reveal a C-terminal glycine. Exposure of the glycine at the C-terminus is essential for ATG8 proteins conjugation to phosphatidylethanolamine (PE) and insertion to membranes, which is necessary for autophagy. Has also an activity of delipidating enzyme for the PE-conjugated forms..
Protein Sequence MEATGTDEVDKLKTKFISAWNNMKYSWVLKTKTYFSRNSPVLLLGKCYHFKYEDEDKTLPAESGCTIEDHVIAGNVEEFRKDFISRIWLTYREEFPQIEGSALTTDCGWGCTLRTGQMLLAQGLILHFLGRAWTWPDALNIENSDSESWTSHTVKKFTASFEASLSGEREFKTPTISLKETIGKYSDDHEMRNEVYHRKIISWFGDSPLALFGLHQLIEYGKKSGKKAGDWYGPAVVAHILRKAVEEARHPDLQGITIYVAQDCTVYNSDVIDKQSASMTSDNADDKAVIILVPVRLGGERTNTDYLEFVKGILSLEYCVGIIGGKPKQSYYFAGFQDDSLIYMDPHYCQSFVDVSIKDFPLETFHCPSPKKMSFRKMDPSCTIGFYCRNVQDFKRASEEITKMLKFSSKEKYPLFTFVNGHSRDYDFTSTTTNEEDLFSEDEKKQLKRFSTEEFVLL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MEATGTDE
-------CCCCCCHH
7.7419413330
11UbiquitinationTGTDEVDKLKTKFIS
CCCHHHHHHHHHHHH
57.99-
11AcetylationTGTDEVDKLKTKFIS
CCCHHHHHHHHHHHH
57.9925953088
15UbiquitinationEVDKLKTKFISAWNN
HHHHHHHHHHHHHHC
38.83-
18PhosphorylationKLKTKFISAWNNMKY
HHHHHHHHHHHCCCE
30.29-
25PhosphorylationSAWNNMKYSWVLKTK
HHHHCCCEEEEEECC
9.3025072903
26PhosphorylationAWNNMKYSWVLKTKT
HHHCCCEEEEEECCC
12.7525072903
31PhosphorylationKYSWVLKTKTYFSRN
CEEEEEECCCCCCCC
25.1825072903
33PhosphorylationSWVLKTKTYFSRNSP
EEEEECCCCCCCCCC
34.7225072903
34PhosphorylationWVLKTKTYFSRNSPV
EEEECCCCCCCCCCE
10.9125072903
36PhosphorylationLKTKTYFSRNSPVLL
EECCCCCCCCCCEEE
21.8225072903
144PhosphorylationDALNIENSDSESWTS
CCCCCCCCCCCCCCC
29.7128348404
158PhosphorylationSHTVKKFTASFEASL
CCEEEEEEEEEEHHH
30.2124719451
160PhosphorylationTVKKFTASFEASLSG
EEEEEEEEEEHHHCC
22.1426471730
164PhosphorylationFTASFEASLSGEREF
EEEEEEHHHCCCCCC
18.8324719451
166PhosphorylationASFEASLSGEREFKT
EEEEHHHCCCCCCCC
35.7924719451
173PhosphorylationSGEREFKTPTISLKE
CCCCCCCCCEEEHHH
30.8728555341
179UbiquitinationKTPTISLKETIGKYS
CCCEEEHHHHHHCCC
46.12-
181PhosphorylationPTISLKETIGKYSDD
CEEEHHHHHHCCCCC
33.1829449344
185PhosphorylationLKETIGKYSDDHEMR
HHHHHHCCCCCHHHH
16.4829449344
186PhosphorylationKETIGKYSDDHEMRN
HHHHHCCCCCHHHHH
39.7923898821
364PhosphorylationIKDFPLETFHCPSPK
ECCCCCCEECCCCCC
26.7730266825
369PhosphorylationLETFHCPSPKKMSFR
CCEECCCCCCCCCCC
55.5430266825
374PhosphorylationCPSPKKMSFRKMDPS
CCCCCCCCCCCCCCC
30.6824719451
381PhosphorylationSFRKMDPSCTIGFYC
CCCCCCCCCEEEEEE
21.4521214269
383PhosphorylationRKMDPSCTIGFYCRN
CCCCCCCEEEEEECC
28.59-
387PhosphorylationPSCTIGFYCRNVQDF
CCCEEEEEECCHHHH
5.8121214269
398PhosphorylationVQDFKRASEEITKML
HHHHHHHHHHHHHHH
39.5327251275
403UbiquitinationRASEEITKMLKFSSK
HHHHHHHHHHHCCCC
48.15-
413PhosphorylationKFSSKEKYPLFTFVN
HCCCCCCCCEEEEEC
13.2726074081
417PhosphorylationKEKYPLFTFVNGHSR
CCCCCEEEEECCCCC
34.0626074081
423PhosphorylationFTFVNGHSRDYDFTS
EEEECCCCCCCCCCC
28.3926074081
426PhosphorylationVNGHSRDYDFTSTTT
ECCCCCCCCCCCCCC
16.3126074081
429PhosphorylationHSRDYDFTSTTTNEE
CCCCCCCCCCCCCHH
23.4326074081
430PhosphorylationSRDYDFTSTTTNEED
CCCCCCCCCCCCHHH
24.6126074081
431PhosphorylationRDYDFTSTTTNEEDL
CCCCCCCCCCCHHHC
34.2826074081
432PhosphorylationDYDFTSTTTNEEDLF
CCCCCCCCCCHHHCC
27.6526074081
433PhosphorylationYDFTSTTTNEEDLFS
CCCCCCCCCHHHCCC
40.5026074081
440PhosphorylationTNEEDLFSEDEKKQL
CCHHHCCCHHHHHHH
51.9728450419
451PhosphorylationKKQLKRFSTEEFVLL
HHHHHCCCCCCEECC
38.6527273156
452PhosphorylationKQLKRFSTEEFVLL-
HHHHCCCCCCEECC-
36.5022617229

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of ATG4C_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ATG4C_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ATG4C_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SPTC1_HUMANSPTLC1physical
20562859
PSMD2_HUMANPSMD2physical
20562859
PRS7_HUMANPSMC2physical
20562859
PRS4_HUMANPSMC1physical
20562859
UBP11_HUMANUSP11physical
20562859
PRKDC_HUMANPRKDCphysical
20562859
PRS8_HUMANPSMC5physical
20562859
PRS6B_HUMANPSMC4physical
20562859
SMC1A_HUMANSMC1Aphysical
20562859

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ATG4C_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY.

TOP